BIOENTERPRISE CORPORATION
Income Statement
Fiscal Year: 2024
Revenues in 2024
$1,149
Investments
81%
Other
19%
Contributions
0%
Government Grants
0%
Fundraising Events
0%
Program Services
0%
Membership Dues
0%
Expenses in 2024
$235,414
Fees to Service Providers
50%
Other
47%
Offices, Occupancy & IT
4%
Grants
0%
Benefits to Members
0%
Salaries & Benefits
0%
Advertising & Promotion
0%
Interest
0%
Depreciation
0%
Revenues
2023
2024
Change
Contributions
$0
$0
-
Government Grants
$0
$0
-
Fundraising Events
$0
$0
-
Program Services
$570,801
$0
-100%
Membership Dues
$0
$0
-
Investments
$91,000
$926
-99%
Other
$3,692,910
$223
-100%
Total Revenues
$4,354,711
$1,149
-100%
Expenses
2023
2024
Change
Grants
$3,600,000
$0
-100%
Benefits to Members
$0
$0
-
Salaries & Benefits
$76,599
$0
-100%
Fees to Service Providers
$429,910
$116,544
-73%
Advertising & Promotion
$0
$0
-
Offices, Occupancy & IT
$56,529
$8,463
-85%
Interest
$2,031
$0
-100%
Depreciation
$254,811
$0
-100%
Other
$188,088
$110,407
-41%
Total Expenses
$4,607,968
$235,414
-95%
Net income
2023
2024
Change
Net income
-$253,257
-$234,265
+7%
Functional Expenses
Summary
2023
2024
Change
Program
$4,194,021
$143,242
-97%
Admin
$413,947
$92,172
-78%
Fundraising
$0
$0
-
Total Expenses
$4,607,968
$235,414
-95%
Copyright 2026. All rights reserved to Chario Inc. (d.b.a. Impala)